German scientists asked to drop tobacco funds

Funding recipients insist they're above board

Written byNed Stafford
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
The lead author of a study alleging that the tobacco industry "enjoys a staggering amount of influence" among leading German scientists has called on scientific institutions, universities, and other research organizations in Germany to ban researchers from accepting tobacco industry money. However, scientists who accepted tobacco funds argue that the money had no influence on their work.The study, recently published in the American Journal of Public Health, focuses on tobacco industry funding from the 1970s through the 1990s. Lead author Thilo Grüning, visiting research fellow at the London School of Hygiene and Tropical Medicine, told The Scientist that he believes the tobacco industry is still funding scientists, a practice he describes as a "white coat strategy" designed to gain influence with influential people. "Scientists that take money from the tobacco industry lose their independence, and this always creates biased and distorted science," he said.Martina Pötschke-Langer, head of the German Cancer Research Center's Unit Cancer Prevention in Heidelberg and the World Health Organization's Collaborating Center for Tobacco Control, told The Scientist that Germany is the largest nation in the European Union with nearly 20 million cigarette smokers, and has historically been a prime target for tobacco industry research funding. "There is no doubt that the tobacco industry is still funding German scientists," she said.As an example, Grüning mentioned Rainer K. Silbereisen, a psychologist at the University of Jena who is president of the International Society for the Study of Behavioural Development (ISSBD). Silbereisen's Curriculum Vitae on his personal Web site lists funding in 2003 from Philip Morris GmbH.In an interview with The Scientist, Silbereisen said that Philip Morris had provided 60,000 euros in funding, emphasizing that the research was for "implementation and evaluation of a life-skills program for the prevention of substance misuse in children and adolescents."He added that he disagreed with Grüning's belief that researchers who accept tobacco industry funding are no longer impartial scientists, and noted that nearly all research funding comes from third parties, including the military industry and breweries, and indirectly from taxpayers.The VdC, Germany's cigarette industry trade organization, did not respond to requests for comment.Grüning said his study is based mainly on documents the tobacco industry was forced to release after 1998 court rulings. "There is no reason to believe this (tobacco industry funding) has changed" since the 1990s, Grüning said. However, he said that following this money is more difficult, since the industry has changed how it communicates, and important documents no longer end up on the Internet.Grüning said that he also would like to see German research funding adopt rules that would refuse co-funding to scientist in receipt of tobacco industry funds. The German Research Foundation (DFG), Germany's largest disburser of public research funds, currently does not exclude scientists who receive tobacco industry funding.In his AJPH article, Grüning also named Helgo Magnussen, medical director of the Grosshansdorf Hospital Center for Pneumonia-ology and Thorax Surgery near Hamburg, who received approximately 260,000 euros for research from the VdC from 1989 through 1993.In an interview with The Scientist, Magnussen said he had not accepted tobacco industry money since 1993, adding that he felt it was unfair to have to answer questions 12 years later. "That is old history," he said. "I am surprised I have to answer these questions again."He said that he had always upheld his scientific integrity and had never felt pressure from the tobacco funding. However, he noted that he "can't argue against" the theory that the tobacco industry may have had large influence with some German scientists. Magnussen also said that he would now refuse any offer of funding from the tobacco industry, despite accepting it in the past. "Smoking is a very harmful thing," he said.scientistnews@yahoo.comLinks within this articleT. Gruning, "Tobacco industry influence on science and scientists in Germany," American Journal of Public Health, November 29, 2005. PM_ID: 16317203.E. Russo," Science in conflict," The Scientist, July 15, 2003 http://www.the-scientist.com/news/20030715/03London School of Hygiene and Tropical Medicine press release, December 4, 2005. http://www.lshtm.ac.uk/news/2005/germantobacco.htmlP. Moore, "Damned if they do ? and broke if they don't," The Scientist, November 11, 2002. http://www.the-scientist.com/news/20021111/03Rainer K. Silbereisen http://www.rainersilbereisen.de/International Society for the Study of Behavioural Development http://www.issbd.org/German Research Foundation http://www.dfg.de/en/index.htmlHelgo Magnussen http://www.kh-grosshansdorf.de/Pneumologie/pneumologie.html
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform